Join us Dec. 1-3 in Nashville for the Digiday Programmatic Marketing Summit
Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
What exactly counts as a creator? The industry still can’t agree
Marketers use creator, influencer and tastemaker interchangeably, but the industry still hasn’t settled on what the labels mean.
Substack job listing hints at a bigger advertising push in 2027
A new product manager role will explore ad-related monetization, suggesting the platform could make ads a bigger part of its business.
Deloitte Digital takes the holdco operating system pitch straight to the CEO
CEOs have never cared much for holdcos. Enterprise solutions, on the other hand, get a meeting.